ADA was not effective in maintaining remission in newly diagnosed GCA patients compared to placebo (58.9% vs. 50%, respectively, P = 0.46, RR 1.20 (95% CI [0.733 to 1.974])). The gene discussed is ADA; the disease is temporal arteritis.